Stay Updated:
Discover the Latest News & Events!

Landesrat Willibald Ehrenhöfer Visits CBmed Headquarters

Landesrat Willibald Ehrenhöfer visited CBmed to explore our cutting-edge biomarker research, microplastic initiatives, and compound screening capabilities.

CBmed Wins 1st Place at Austria’s Leading Companies 2025 – National Award in the “Small Companies” Category

Following its regional success in Styria, CBmed has now achieved national recognition at the Austria’s Leading Companies (ALC) 2025 awards. At the gala held in Vienna, CBmed was awarded 1st place in the “Small Companies” category for the entire country, marking an important milestone in the company’s development.

CBmed Tops Austria’s Leading Companies 2025 in Styria

CBmed has claimed 1st place in the “Small Companies” category at the Austria’s Leading Companies 2025 awards for Styria. Recognized for its growth, innovation, and international collaborations in precision medicine, CBmed celebrated the honor alongside its team and partners at the Helmut List Halle gala.

CBmed Successfully Achieves ISO 9001 Certification

CBmed has successfully passed the ISO 9001 audit for its headquarters and core technology laboratories, marking an important milestone in its commitment to quality and excellence.

Stadtrat Dr. Riegler Visits CBmed to Learn About Cutting-Edge Research

Dr. Günter Riegler toured CBmed’s headquarters, labs, and innovation spaces, gaining insights into groundbreaking biomarker research.

Can Plastic Fasting Reduce Microplastics in the Body?

Kleine Zeitung highlights a groundbreaking CBmed study under the microONE project, exploring whether “plastic fasting” can lower microplastic levels in the human body and its potential health impacts.

CBmed Celebrates 10 Years of Revolutionizing Precision Medicine

CBmed celebrated its 10th anniversary on September 23, 2024, marking a decade of advancements in precision medicine and biomarker research, while reflecting on its growth into a leader in personalized healthcare through strategic collaborations and cutting-edge innovations.

microONE Project Featured in Ö1 Podcast on Microplastics

CBmed recently featured on the Ö1 podcast, discussing the health impacts of microplastics and showcasing the vital work of the microONE project in addressing this global issue.

Probiotics Show Promise for COVID-19 Recovery

A study by CBmed and the Medical University of Graz suggests probiotics could accelerate COVID-19 recovery by restoring gut health.

CBmed and Boehringer Ingelheim’s Strategic Partnership to Transform Cancer Care

Boehringer Ingelheim and CBmed have announced a strategic partnership to accelerate the development of innovative cancer therapies through advanced translational medicine approaches.

CBmed Joins ATTRACT to Transform Glioblastoma Care

CBmed announces its participation in the groundbreaking ATTRACT project, aimed at revolutionizing glioblastoma treatment through personalized therapies and innovative drug screening.